Phase 3 Study of Submicron Particle, Lower-Dose Diclofenac For Acute Pain – Monthly Prescribing Reference

Iroko Pharmaceuticals announced Phase 3 study results that showed patients treated with the company’s submicron particle, lower-dose diclofenac (18mg and 35mg) experienced significant pain relief post surgery compared with placebo (P=0.01 and P<0.001 …

Leave a Reply

Your email address will not be published.

*